Product information and disease descriptionPlace of product in therapyApproaches to treatment
Expected outcomes of therapy
1 evidence topic · 1 source
Imlifidase
Kidney transplantation in highly sensitized patients
- Manufacturer
- Hansa Biopharma
- Regulatory submission
- BLA submitted December 2025
- Last updated